Similar articles

• [Experiences with monocomponent insulin treatment].

  Korp W, Levett RE. Korp W, et al. Wien Klin Wochenschr. 1973 May 4;85(18):326-30. Wien Klin Wochenschr. 1973. PMID: 4699490 German. No abstract available.
• Immunogenicity of insulin of various origins.

  Reeves WG. Reeves WG. Neth J Med. 1985;28 Suppl 1:43-6. Neth J Med. 1985. PMID: 3892338 No abstract available.
• Recombinant DNA insulins and diabetes mellitus. Short review and perspective.

  van der Veen EA, Heine RJ, van der Meer J. van der Veen EA, et al. Neth J Med. 1986;29(2):62-4. Neth J Med. 1986. PMID: 3513036 No abstract available.
• [Synthesis of human proinsulin and its clinical significance].

  Qian RL, Xiang KS. Qian RL, et al. Zhonghua Yi Xue Za Zhi. 1986 Sep;66(9):564-6. Zhonghua Yi Xue Za Zhi. 1986. PMID: 3098377 Review. Chinese. No abstract available.
• Chemical and biological aspects of insulin and proinsulin.

  Steiner DF, Terris S, Chan SJ, Rubenstein AH. Steiner DF, et al. Acta Med Scand Suppl. 1976;601:55-107. Acta Med Scand Suppl. 1976. PMID: 16981321 Review. No abstract available.